bilateral pes planus. On questioning she said that she bruised easily, was double jointed and suffered from rectal prolapse. She was tender on the lumbar spine and the neurological examination in the lower limb was normal. Haematological and radiological investigations excluded myeloma or other malignant deposits.
A diagnosis of EDS type 2 was made. She underwent bone densitometry examination by dual energy x ray absorptiometry which revealed Z scores of-1-21 (T score -2-69) in the lumbar spine and -1-88 (T score -3-55) in the femoral neck. She was treated with analgesics and hydrotherapy and commenced hormone replacement therapy (HRT). Over the next four years, she consistently gained bone density at the lumbar spine, though after the initial gains HRT failed to maintain the bone mineral density (BMD) at the femoral neck (fig) . Her backache has remained under control and she has had no new fractures.
In the past three years we have seen six other patients with EDS: four females aged 16-62 and two males aged 55 and 70. None of them was known to have EDS; they were referred by their general practitioner for assessment of bone densitometry at their own request. Detailed history failed to identify any predisposing factors for osteoporosis and diagnoses ofEDS were made for the first time as a result of clinical characteristics. All the patients had low BMD in either the lumbar spine or the femoral neck (table). For the seven patients taken together, the average Z score was -1-4 (T score -2-26) at the lumbar spine and -1-83 (T score -3 2) at the femoral neck. April 1986 . At that time, renal biopsy showed amyloid deposition that was quantitatively similar to that observed in the first biopsy specimen. Electron microscopy revealed deposition of amyloid mainly in the mesangial region and partly in the subepithelium (fig). As the TA was also active, the dose of prednisolone was increased to 40 mg/day; DMSO was also reinstituted. This led to a gradual decrease in urinary protein until March 1987; when none could be detected and DMSO administration was stopped. The patient continued to receive prednisolone 7-5 mg daily. Although some inflammatory findings persist (0-81 mg/ dl of C reactive protein, ESR 20 mm/h) no proteinuria is currently present and renal function is normal (creatinine 0-61 mg/dl). Thirteen years after the onset of amyloidosis, the patient is relatively well.
There have been occasional reports of patients with both TA and the nephrotic syndrome, most associated with amyloidosis; only six cases have been reported in the English literature.3
The course of renal amyloidosis is typically progressive. Once the nephrotic syndrome becomes established, or when azotaemia appears, the prognosis is poor:2 fewer than 10% of patients with the nephrotic syndrome survive as long as three years. 4 However, remission has been achieved in patients with amyloidosis secondary to tuberculosis or bums,5 with resolution of the underlying chronic inflammation. Fritz et al6 described a patient with primary systemic amyloidosis who survived for 19 years after treatment with melphalan and prednisolone.
There is no satisfactory treatment for renal amyloidosis. Steroid administration is ineffective. 7 We were able to induce remission of the nephrotic syndrome by a combination of a steroid with DMSO in a patient who was receiving the steroid treatment for her underlying TA, not for the amyloidosis. While prednisolone alone was ineffective for controlling the proteinuria, the addition of DMSO proved effective; its withdrawal led to a relapse of the nephrotic syndrome but readministration was again effective in controlling the nephrotic syndrome.
DMSO is an industrial solvent that was first used by Isobe A 26 year old male medical student was referred to the rheumatology outpatient unit because of migratory arthritis and multiple superficial thrombophlebitis. He had been in good health until one year earlier, when he had worked for two months in a hospital in Namibia (Africa). Two months after his return to Germany he complained of red and painful nodules at the dorsum of both feet, which persisted for several months. After a further two months he developed migratory arthritis of the joints of the fingers and toes. A biopsy of a cutaneous nodule was performed which showed inflammatory infiltration of the wall of a thrombotic vein. The histology confirmed the clinical diagnosis of thrombophlebitis. The patient received topical therapy (venous compression, local heparin) but was referred to our clinic because of persistence of symptoms. 
